Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 38,000,000 shares of common stock of Plug Power Inc. for $845.5…
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Datadog, Inc. of $747.5 million aggregate principal amount of its 0.125%…
Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …
Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…
Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…
Davis Polk advised Youdao, Inc. on its SEC-registered initial public offering of 5,600,000 American Depositary Shares. Each ADS represents one Class A ordinary share of Youdao. Youdao has…
Davis Polk advised the underwriters in connection with the $648 million initial public offering by Datadog, Inc. of 24,000,000 shares of its Class A common stock. The Class A common stock…
Davis Polk is advising the Goldman Sachs Merchant Banking Division in connection with its investment in MedVet.
Founded in 1869, The Goldman Sachs Group, Inc. is a leading global investment…
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $690 million aggregate principal amount of its 0.25% convertible senior notes due 2024,…